175 related articles for article (PubMed ID: 35145041)
41. Combining European and U.S. risk prediction models with polygenic risk scores to refine cardiovascular prevention: the CoLaus|PsyCoLaus Study.
de La Harpe R; Thorball CW; Redin C; Fournier S; Müller O; Strambo D; Michel P; Vollenweider P; Marques-Vidal P; Fellay J; Vaucher J
Eur J Prev Cardiol; 2023 May; 30(7):561-571. PubMed ID: 36652418
[TBL] [Abstract][Full Text] [Related]
42. Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
Shah R; Matthews GJ; Shah RY; McLaughlin C; Chen J; Wolman M; Master SR; Chai B; Xie D; Rader DJ; Raj DS; Mehta NN; Budoff M; Fischer MJ; Go AS; Townsend RR; He J; Kusek JW; Feldman HI; Foulkes AS; Reilly MP;
Am J Kidney Dis; 2015 Aug; 66(2):266-73. PubMed ID: 25795074
[TBL] [Abstract][Full Text] [Related]
43. Study on the prediction model of atherosclerotic cardiovascular disease in the rural Xinjiang population based on survival analysis.
Qian X; Keerman M; Zhang X; Guo H; He J; Maimaitijiang R; Wang X; Ma J; Li Y; Ma R; Guo S
BMC Public Health; 2023 Jun; 23(1):1041. PubMed ID: 37264356
[TBL] [Abstract][Full Text] [Related]
44. Estimation of Atherosclerotic Cardiovascular Disease Risk Among Patients in the Veterans Affairs Health Care System.
Vassy JL; Lu B; Ho YL; Galloway A; Raghavan S; Honerlaw J; Tarko L; Russo J; Qazi S; Orkaby AR; Tanukonda V; Djousse L; Gaziano JM; Gagnon DR; Cho K; Wilson PWF
JAMA Netw Open; 2020 Jul; 3(7):e208236. PubMed ID: 32662843
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of Atherosclerotic Cardiovascular Risk Prediction Models in China: Results From the CHERRY Study.
Liu X; Shen P; Zhang D; Sun Y; Chen Y; Liang J; Wu J; Zhang J; Lu P; Lin H; Tang X; Gao P
JACC Asia; 2022 Feb; 2(1):33-43. PubMed ID: 36340248
[TBL] [Abstract][Full Text] [Related]
46. Prediction of the 10-year risk of atherosclerotic cardiovascular disease in the Korean population.
Park S; Kim YG; Ann SH; Cho YR; Kim SJ; Han S; Park GM
Epidemiol Health; 2023; 45():e2023052. PubMed ID: 37189276
[TBL] [Abstract][Full Text] [Related]
47. Assessment of Coronary Artery Calcium Scoring to Guide Statin Therapy Allocation According to Risk-Enhancing Factors: The Multi-Ethnic Study of Atherosclerosis.
Patel J; Pallazola VA; Dudum R; Greenland P; McEvoy JW; Blumenthal RS; Virani SS; Miedema MD; Shea S; Yeboah J; Abbate A; Hundley WG; Karger AB; Tsai MY; Sathiyakumar V; Ogunmoroti O; Cushman M; Savji N; Liu K; Nasir K; Blaha MJ; Martin SS; Al Rifai M
JAMA Cardiol; 2021 Oct; 6(10):1161-1170. PubMed ID: 34259820
[TBL] [Abstract][Full Text] [Related]
48. Utility of Nontraditional Risk Markers in Atherosclerotic Cardiovascular Disease Risk Assessment.
Yeboah J; Young R; McClelland RL; Delaney JC; Polonsky TS; Dawood FZ; Blaha MJ; Miedema MD; Sibley CT; Carr JJ; Burke GL; Goff DC; Psaty BM; Greenland P; Herrington DM
J Am Coll Cardiol; 2016 Jan; 67(2):139-147. PubMed ID: 26791059
[TBL] [Abstract][Full Text] [Related]
49. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.
Kavousi M; Leening MJ; Nanchen D; Greenland P; Graham IM; Steyerberg EW; Ikram MA; Stricker BH; Hofman A; Franco OH
JAMA; 2014 Apr; 311(14):1416-23. PubMed ID: 24681960
[TBL] [Abstract][Full Text] [Related]
50. Cardiovascular Risk Prediction Functions Underestimate Risk in HIV Infection.
Triant VA; Perez J; Regan S; Massaro JM; Meigs JB; Grinspoon SK; D'Agostino RB
Circulation; 2018 May; 137(21):2203-2214. PubMed ID: 29444987
[TBL] [Abstract][Full Text] [Related]
51. Impact of Replacing the Pooled Cohort Equation With Other Cardiovascular Disease Risk Scores on Atherosclerotic Cardiovascular Disease Risk Assessment (from the Multi-Ethnic Study of Atherosclerosis [MESA]).
Qureshi WT; Michos ED; Flueckiger P; Blaha M; Sandfort V; Herrington DM; Burke G; Yeboah J
Am J Cardiol; 2016 Sep; 118(5):691-6. PubMed ID: 27445216
[TBL] [Abstract][Full Text] [Related]
52. High Sensitivity Troponin and Risk of Incident Peripheral Arterial Disease in Chronic Kidney Disease (from the Chronic Renal Insufficiency Cohort [CRIC] Study).
Janus SE; Hajjari J; Al-Kindi SG
Am J Cardiol; 2020 Feb; 125(4):630-635. PubMed ID: 31831152
[TBL] [Abstract][Full Text] [Related]
53. Dietary Behavior and Predicted 10-Year Risk for a First Atherosclerotic Cardiovascular Disease Event Using the Pooled Cohort Risk Equations Among US Adults.
Edwards MK; Crush E; Loprinzi PD
Am J Health Promot; 2018 Jul; 32(6):1447-1451. PubMed ID: 27609908
[TBL] [Abstract][Full Text] [Related]
54. Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm.
Hageman SHJ; McKay AJ; Ueda P; Gunn LH; Jernberg T; Hagström E; Bhatt DL; Steg PG; Läll K; Mägi R; Gynnild MN; Ellekjær H; Saltvedt I; Tuñón J; Mahíllo I; Aceña Á; Kaminski K; Chlabicz M; Sawicka E; Tillman T; McEvoy JW; Di Angelantonio E; Graham I; De Bacquer D; Ray KK; Dorresteijn JAN; Visseren FLJ
Eur Heart J; 2022 May; 43(18):1715-1727. PubMed ID: 35165703
[TBL] [Abstract][Full Text] [Related]
55. Myeloperoxidase and the Risk of CKD Progression, Cardiovascular Disease, and Death in the Chronic Renal Insufficiency Cohort (CRIC) Study.
Correa S; Pena-Esparragoza JK; Scovner KM; Waikar SS; Mc Causland FR
Am J Kidney Dis; 2020 Jul; 76(1):32-41. PubMed ID: 31864821
[TBL] [Abstract][Full Text] [Related]
56. Association between atherosclerotic cardiovascular diseases risk and renal outcome in patients with type 2 diabetes mellitus.
Ren H; Zhao L; Zou Y; Wang Y; Zhang J; Wu Y; Zhang R; Wang T; Wang J; Zhu Y; Guo R; Xu H; Li L; Cooper ME; Liu F
Ren Fail; 2021 Dec; 43(1):477-487. PubMed ID: 33685340
[TBL] [Abstract][Full Text] [Related]
57. Implications of Social Disadvantage Score in Cardiovascular Outcomes and Risk Assessment: Findings From the Multi-Ethnic Study of Atherosclerosis.
Hammoud A; Chen H; Ivanov A; Yeboah J; Nasir K; Cainzos-Achirica M; Bertoni A; Khan SU; Blaha M; Herrington D; Shapiro MD
Circ Cardiovasc Qual Outcomes; 2023 Jul; 16(7):e009304. PubMed ID: 37403692
[TBL] [Abstract][Full Text] [Related]
58. Use of Long-term Cumulative Blood Pressure in Cardiovascular Risk Prediction Models.
Pool LR; Ning H; Wilkins J; Lloyd-Jones DM; Allen NB
JAMA Cardiol; 2018 Nov; 3(11):1096-1100. PubMed ID: 30193291
[TBL] [Abstract][Full Text] [Related]
59. Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol Guidelines.
Marston NA; Bonaca MP; Jarolim P; Goodrich EL; Bhatt DL; Steg PG; Cohen M; Storey RF; Johanson P; Wiviott SD; Braunwald E; Sabatine MS; Morrow DA
JAMA Cardiol; 2020 Nov; 5(11):1255-1262. PubMed ID: 32756916
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
